Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

3 years ago 292

Moderna banal was climbing successful premarket trading Friday aft an expert astatine Piper Sandler upgraded the shares and said the existent terms level was an charismatic introduction point.

Edward Tenthoff upgraded Moderna (ticker: MRNA) banal to Overweight from Neutral but near the people terms unchanged astatine $445, implying a adjacent 31% upside to the shares. Piper Sandler had downgraded the shares to neutral connected Aug. 6.

“Shares...

Read Entire Article

Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

Related

How To Dominate Search Engine Rankings with Guest Posts

The Truth Behind Trading Semiconductor (Chip) Stocks

Is the stock market open today? Here are the trading hours o...

Global stocks advance with U.S. exchanges shut as traders wa...

Trending

Popular

FDA to Add Warning Label to Pfizer, Moderna Vaccines About M...

New York City Adds 629,000 People, Defying Predictions of It...

Astros split doubleheader with Tigers thanks to late home ru...

Blake Shelton and Gwen Stefani are married

Balenciaga Spring